Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ruediger Streicher is active.

Publication


Featured researches published by Ruediger Streicher.


Journal of Biological Chemistry | 2008

Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase.

Alexander Pautsch; Nadja Stadler; Oliver Wissdorf; Elke Langkopf; Werner Moreth; Ruediger Streicher

Disrupting the interaction between glycogen phosphorylase and the glycogen targeting subunit (GL) of protein phosphatase 1 is emerging as a novel target for the treatment of type 2 diabetes. To elucidate the molecular basis of binding, we have determined the crystal structure of liver phosphorylase bound to a GL-derived peptide. The structure reveals the C terminus of GL binding in a hydrophobically collapsed conformation to the allosteric regulator-binding site at the phosphorylase dimer interface. GL mimics interactions that are otherwise employed by the activator AMP. Functional studies show that GL binds tighter than AMP and confirm that the C-terminal Tyr-Tyr motif is the major determinant for GL binding potency. Our study validates the GL-phosphorylase interface as a novel target for small molecule interaction.


Archive | 2006

Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives

Frank Himmelsbach; Roland Maier; Peter Eickelmann; Leo Thomas; Edward Leon Barsoumian; Klaus Dugi; Sabine Pinnetti; Regine Ritter; Ruediger Streicher; Koichi Fujita; Toshihiro Hatanaka; Nozomu Ishida; Katsumi Maezono; Koji Ohsumi


Archive | 2008

Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions

Holger Wagner; Elke Langkopf; Ruediger Streicher; Matthias Eckhardt; Annette Schuler-Metz; Alexander Pautsch; Corinna Schoelch


Archive | 2008

Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus

Holger Wagner; Elke Langkopf; Matthias Eckhardt; Ruediger Streicher; Corinna Schoelch; Annette Schuler-Metz; Alexander Pautsch


Archive | 2003

Use of substituted 2-phenylbenzimidazoles as medicaments

Ruediger Streicher; Juergen Mack; Rainer Walter; Ingo Konetzki; Thomas Trieselmann; Volkhard Austel


Archive | 2008

Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes

Holger Wagner; Elke Langkopf; Matthias Eckhardt; Ruediger Streicher; Corinna Schoelch; Annette Schuler-Metz; Alexander Pautsch


Archive | 2009

New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments

Elke Langkopf; Frank Himmelsbach; Juergen Mack; Alexander Pautsch; Corinna Schoelch; Annette Schuler-Metz; Ruediger Streicher; Holger Wagner


Archive | 2008

ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS

Elke Langkopf; Alexander Pautsch; Corinna Schoelch; Annette Schuler-Metz; Ruediger Streicher; Holger Wagner


Archive | 2011

Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation

Holger Wagner; Daniela Berta; Riccardo Giovannini; Alessandro Mazzacani; Ruediger Streicher; Klaus Fuchs


Archive | 2005

Cyanothiophenes, their preparation and their use in pharmaceutical compositions

Ralf Anderskewitz; Gerd Morschhaeuser; Ruediger Streicher; Thomas Trieselmann; Rainer Walter

Collaboration


Dive into the Ruediger Streicher's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge